IL79841A - 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL79841A
IL79841A IL79841A IL7984186A IL79841A IL 79841 A IL79841 A IL 79841A IL 79841 A IL79841 A IL 79841A IL 7984186 A IL7984186 A IL 7984186A IL 79841 A IL79841 A IL 79841A
Authority
IL
Israel
Prior art keywords
alkyl
phenyl
hydrogen
thiadiazole
dihydro
Prior art date
Application number
IL79841A
Other languages
English (en)
Other versions
IL79841A0 (en
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858521697A external-priority patent/GB8521697D0/en
Priority claimed from GB858524932A external-priority patent/GB8524932D0/en
Priority claimed from GB858530143A external-priority patent/GB8530143D0/en
Priority claimed from GB868609793A external-priority patent/GB8609793D0/en
Priority claimed from GB868612060A external-priority patent/GB8612060D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Priority to IL97823A priority Critical patent/IL97823A/xx
Publication of IL79841A0 publication Critical patent/IL79841A0/xx
Priority claimed from SU874202059A external-priority patent/RU1804458C/ru
Priority to IL97823A priority patent/IL97823A0/xx
Publication of IL79841A publication Critical patent/IL79841A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL79841A 1985-08-31 1986-08-26 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them IL79841A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL97823A IL97823A (en) 1985-08-31 1986-08-26 5-substituted 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives
IL97823A IL97823A0 (en) 1985-08-31 1991-04-10 Heterocyclic compounds

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858521697A GB8521697D0 (en) 1985-08-31 1985-08-31 Nitrogen & sulphur heterocycles
GB858524932A GB8524932D0 (en) 1985-10-09 1985-10-09 Nitrogen & sulphur heterocycles
GB858530143A GB8530143D0 (en) 1985-12-06 1985-12-06 Nitrogen
GB868609793A GB8609793D0 (en) 1986-04-22 1986-04-22 Nitrogen containing heterocycles
GB868612060A GB8612060D0 (en) 1986-05-17 1986-05-17 Nitrogen containing heterocycles
SU874202059A RU1804458C (ru) 1985-08-31 1987-02-09 Способ получени производных 1,3,4-тиадиазол-2-карбоновых кислот или их фармацевтически приемлемых солей, сложных эфиров или амидов

Publications (2)

Publication Number Publication Date
IL79841A0 IL79841A0 (en) 1986-11-30
IL79841A true IL79841A (en) 1992-02-16

Family

ID=27546912

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79841A IL79841A (en) 1985-08-31 1986-08-26 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4927822A (ja)
EP (1) EP0217519B1 (ja)
JP (1) JPH0788365B2 (ja)
KR (1) KR940009528B1 (ja)
AT (1) ATE72431T1 (ja)
AU (1) AU591165B2 (ja)
BE (1) BE905351A (ja)
CA (1) CA1305286C (ja)
CH (1) CH671397A5 (ja)
DK (1) DK406386A (ja)
FI (1) FI87205C (ja)
FR (1) FR2586679B1 (ja)
GR (1) GR862234B (ja)
IE (1) IE59432B1 (ja)
IL (1) IL79841A (ja)
LU (1) LU86569A1 (ja)
NO (1) NO166180C (ja)
NZ (1) NZ217398A (ja)
PT (1) PT83277B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8825541D0 (en) * 1988-11-01 1988-12-07 Fisons Plc Formulation
WO1994020460A1 (en) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Chemical compounds
KR100915287B1 (ko) * 2001-12-11 2009-09-03 교와 핫꼬 기린 가부시키가이샤 티아디아졸린 유도체
WO2004092147A1 (ja) 2003-04-18 2004-10-28 Kyowa Hakko Kogyo Co., Ltd. M期キネシン阻害剤
JPWO2004111023A1 (ja) * 2003-06-10 2006-07-27 協和醗酵工業株式会社 チアジアゾリン−1−オキシド誘導体
CA2528433A1 (en) * 2003-06-10 2004-12-23 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivative
CA2542034A1 (en) * 2003-10-10 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivatives
US7449486B2 (en) * 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
EP1867640A4 (en) * 2005-03-22 2010-07-14 Kyowa Hakko Kirin Co Ltd MEANS FOR TREATING SOLID TUMORS
CA2602559A1 (en) * 2005-03-22 2006-09-28 Kyowa Hakko Kogyo Co., Ltd. Agent for treatment of hematopoietic tumor
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
WO2006137490A1 (ja) 2005-06-24 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. 再狭窄治療剤
DE102006002065B4 (de) * 2006-01-16 2007-11-29 Infineon Technologies Austria Ag Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand
NZ575350A (en) 2006-08-21 2012-02-24 Synta Pharmaceuticals Corp Bis(phenylcarbonothioyl)hydrazide derivatives
WO2008042928A2 (en) * 2006-10-03 2008-04-10 Array Biopharma, Inc. Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof
TW200940050A (en) * 2007-11-28 2009-10-01 Synta Pharmaceuticals Corp Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)
EP2225201A2 (en) * 2007-11-28 2010-09-08 Synta Pharmaceuticals Corp. Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198517A (en) * 1976-12-03 1980-04-15 E. R. Squibb & Sons, Inc. Histidine derivatives
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4254267A (en) * 1979-10-25 1981-03-03 E. R. Squibb & Sons, Inc. Mercaptoacyldihydropyrazole carboxylic acid derivatives
US4312990A (en) * 1980-09-11 1982-01-26 E. R. Squibb & Sons, Inc. 1-Mercaptoacyl-3-[(aminosulfonyl) phenyl]-4,5-dihydro-1H-pyrazole-5-carboxylic acid
GR75019B (ja) * 1980-09-17 1984-07-12 Univ Miami

Also Published As

Publication number Publication date
FI863488A (fi) 1987-03-01
AU591165B2 (en) 1989-11-30
FR2586679B1 (fr) 1988-12-30
IE59432B1 (en) 1994-02-23
IL79841A0 (en) 1986-11-30
PT83277A (en) 1986-09-01
NO166180B (no) 1991-03-04
IE862322L (en) 1987-02-28
JPS6253976A (ja) 1987-03-09
KR870002107A (ko) 1987-03-30
GR862234B (en) 1986-12-31
NO863457D0 (no) 1986-08-28
EP0217519B1 (en) 1992-02-05
NZ217398A (en) 1989-04-26
NO863457L (no) 1987-03-02
ATE72431T1 (de) 1992-02-15
DK406386A (da) 1987-03-01
US4927822A (en) 1990-05-22
CH671397A5 (ja) 1989-08-31
EP0217519A1 (en) 1987-04-08
PT83277B (pt) 1989-03-30
FI87205B (fi) 1992-08-31
NO166180C (no) 1991-06-19
JPH0788365B2 (ja) 1995-09-27
FR2586679A1 (fr) 1987-03-06
AU6179886A (en) 1987-03-05
KR940009528B1 (ko) 1994-10-14
DK406386D0 (da) 1986-08-26
BE905351A (fr) 1987-03-02
CA1305286C (en) 1992-07-14
FI87205C (fi) 1992-12-10
LU86569A1 (fr) 1986-12-02
FI863488A0 (fi) 1986-08-28

Similar Documents

Publication Publication Date Title
IL79841A (en) 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES8609247A1 (es) Un procedimiento para la preparacion de derivados del indol
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
SE8406200D0 (sv) Indolderivat
NO158459C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutanderivater.
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
ZA899321B (en) Indole derivatives,process for preparing them and pharmaceutical compositions containing them
MY101878A (en) 1,3,4-thiadiazole
SE8302452D0 (sv) Method for treatment of senile dementia
ES8606258A1 (es) Procedimiento de preparacion de eteres oximas basicos, y de sus sales de adicion acidas farmaceuticamente aceptables
DE3860117D1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
NZ238431A (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivatives; pharmaceutical compositions and preparatory processes
ES8608509A1 (es) Procedimiento para preparar nuevos derivador de 2-(1-imidazolil)-etanol
ZA838139B (en) Semicarbazides,process for preparing these,and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void